A purple and pink letter v on a white background.
March 31, 2020

Webinar Recording: NeoGraft® - Capitalize on the Fastest Growing Market Opportunity

It is evident that the hair restoration market has grown significantly over the recent years as more patients explore solutions to deal with hair loss. Projections show that the global hair transplant market share is expected to surpass USD $24.8 billion by 2024 . Discover a few more reasons why your practice should invest in hair restoration solutions to meet this growing demand.

The FUE (Follicular Unit Extraction) procedure has established itself as an efficient and effective method for hair restoration over the years. Systems like our NeoGraft® device are great tools to help aid the transition of your practice into hair restoration. To better understand the value that NeoGraft® can bring to businesses who are looking to expand their services, we’ve turned to Dr. Richard Chaffoo, triple board-certified plastic surgeon of La Jolla Plastic Surgery , to share his experience and expertise about the comprehensive benefits of owning and operating a NeoGraft® device. The recording of the live webinar is available below:

NeoGraft® FUE Hair Restoration

Being one of the first automated FUE systems in the market, NeoGraft® ’s pneumatic motor delivers precise pressures for standardized extraction and implantation. The inefficiencies of manual tools and procedures are eliminated by the system while offering more consistent outcomes for the patient. The procedure is minimally invasive, does not leave linear scarring, and delivers high patient satisfaction.

In addition to helping you deliver top treatments for your patients with cutting-edge technology, we are also committed to ensuring that your practice is successful, which is why we offer a comprehensive business solution backed by unparalleled clinical , technical, and business development support. Discover your options with Venus Concept today by contacting an expert using the button below.

July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.
May 22, 2026
Skin cancer radiotherapy improves treatment precision and patient outcomes. Learn how dermatology clinics use it in modern care plans.